-
Jio Platforms
1,490.00 1,423.80(%) -
Reliance Industries
1,182.00 1,611.20(%) -
NSE
1,795.00 1,878.00(%) -
Tube Investments
2,098.60 2,006.00(%) -
PTC Industries
24,750.00 26,049.95(%) -
Dalmia BharatLtd
1,403.50 1,464.85(%) -
Aeroflex
579.00 613.50(%) -
Pidilite Inds.
1,429.05 1,707.95(%) -
The Bombay Burmah
1,175.60 1,108.20(%) -
Birlasoft Ltd
352.25 473.75(%) -
Billionbrains
193.00 227.00(%) -
Cholaman.Inv.&Fn
1,589.95 1,952.00(%) -
Bajaj Finance
932.45 1,177.60(%) -
Max Healthcare
848.40 797.00(%) -
Adani Ports
1,867.75 1,891.80(%) -
M & M Fin. Serv.
256.60 253.30(%) -
HDFC Bank
678.05 668.90(%) -
Acutaas Chemical
4,031.85 3,977.00(%) -
Coromandel Inter
1,734.65 2,496.10(%) -
Kotak Mah. Bank
455.50 453.00(%)
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
Citurgia Biochemicals Ltd Chemicals
- MNC Associate
- BSE Code : 115.0
- ISIN : INE795B01031
-
Today’s Low
102.45 -
Today’s High
102.45
-
Open
102.45 -
Perv Close
103.45 -
52W Low
47.40 -
52W High
212.00
Key Indicators
-
P/E(TTM)
0.00
-
Mar.Cap (₹Cr.)
1,353.32
-
Div & Yield %
0.00
-
Book Value(₹)
-0.77
-
Debt-Equity Ratio
-0.97
-
AGM Date
19-Oct-2026
-
EPS
0.00
-
P/E Ratio
0.00
Financials Ratios
-
Debt-Equity Ratio
-
-
Mar.Cap (₹Cr.)
1,353.32
-
RONW (%)
-
-
ROCE (%)
-
Score Board
-
Equity (₹ in Cr.)
26.42
-
BV (₹)
-0.80
-
Sales( ₹ in Cr.)
0.00
-
NP (in Cr.)
-0.74
-
NP Var(%)
-75.0
-
Div%
0.0
-
CPS (₹)
0.00
-
EPS (₹)
-0.10
-
Traded Value (₹ in Lakhs)
1,353.32
-
52 Week High
212.00
-
52 Week Low
47.40
-
Price BSE
102.0
-
Price NSE
4.00
-
Market Capital( in Cr.)
1,353.32
-
P/C Ratio
-2,606.60
-
P/E Ratio
-1,814.60
-
Price Vs.BV
-0.10
-
01-Oct-2026( 05:30)
Corporate News - Citur... - <p>Citurgia Biochemicals Limit...
-
30-Sep-2026( 02:24)
Corporate News - Citur... - <p>Citurgia Biochemicals Limit...
-
18-Sep-2026( 06:07)
Corporate News - Citur... - <p>Citurgia Biochemicals Limit...
-
04-Aug-2026( 04:40)
Corporate News - Citur... - Citurgia Biochemicals Limited...
Navigate The Market With Confidence
Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions
Financials
All Values are in (₹Cr)| Particulars(INCOME) | 2025 Mar | 2024 Mar | 2023 Mar | 2022 Mar | 2021 Mar | 2020 Mar |
|---|---|---|---|---|---|---|
| INCOME : | ||||||
| Sales Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EXPENDITURE : | ||||||
| Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Power and Fuel Cost | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Employee Cost | 0.17 | 0.17 | 0.16 | 0.16 | 0.14 | 0.10 |
| Other Manufacturing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling and Administration Expenses | 0.02 | 0.08 | 0.04 | 0.02 | 0.23 | 0.01 |
| Miscellaneous Expenses | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 |
| Employee Benefit Expenses | 0.17 | 0.17 | 0.16 | 0.16 | 0.14 | 0.10 |
| Less: Preoperative Expenditure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Expenses | 0.20 | 0.25 | 0.21 | 0.18 | 0.37 | 0.12 |
| Operating Profit | -0.20 | -0.25 | -0.21 | -0.18 | -0.37 | -0.12 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | -0.20 | -0.25 | -0.21 | -0.18 | -0.37 | -0.12 |
| Depreciation | 0.23 | 0.23 | 0.23 | 0.23 | 0.24 | 0.28 |
| Profit Before Tax | -0.43 | -0.48 | -0.44 | -0.41 | -0.61 | -0.40 |
| Current Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Reported Net Profit | -0.42 | -0.48 | -0.44 | -0.40 | -0.61 | -0.40 |
| Extraordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Net Profit | -0.42 | -0.48 | -0.44 | -0.40 | -0.61 | -0.40 |
| Adjustment below Net Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| P & L Balance brought forward | -35.56 | -35.09 | -34.65 | -34.25 | -33.63 | -33.24 |
| Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| P & L Balance carried down | -35.98 | -35.56 | -35.09 | -34.65 | -34.25 | -33.63 |
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend Per Share(Rs) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Earnings Per Share-Unit Curr | -0.16 | -0.18 | -0.17 | -0.15 | -0.23 | -0.15 |
| Earnings Per Share(Adj)-Unit Curr | - | - | - | - | - | - |
| Book Value | -3.59 | -3.43 | -3.25 | -3.09 | -2.93 | -2.70 |
| Book Value(Adj)-Unit Curr | - | - | - | - | - | - |
